Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Varlilumab by Celldex Therapeutics for Mantle Cell Lymphoma: Likelihood of Approval
Varlilumab is under clinical development by Celldex Therapeutics and currently in Phase II for Mantle Cell Lymphoma. According to GlobalData,...
Data Insights
Varlilumab by Celldex Therapeutics for Marginal Zone B-cell Lymphoma: Likelihood of Approval
Varlilumab is under clinical development by Celldex Therapeutics and currently in Phase II for Marginal Zone B-cell Lymphoma. According to...